GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharvaris NV (NAS:PHVS) » Definitions » EV-to-FCF

Pharvaris NV (Pharvaris NV) EV-to-FCF : -5.49 (As of Jun. 05, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Pharvaris NV EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Pharvaris NV's Enterprise Value is $547.64 Mil. Pharvaris NV's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was $-99.74 Mil. Therefore, Pharvaris NV's EV-to-FCF for today is -5.49.

The historical rank and industry rank for Pharvaris NV's EV-to-FCF or its related term are showing as below:

PHVS' s EV-to-FCF Range Over the Past 10 Years
Min: -15.05   Med: 0   Max: 0
Current: -5.49

PHVS's EV-to-FCF is ranked worse than
100% of 379 companies
in the Biotechnology industry
Industry Median: 8.31 vs PHVS: -5.49

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-05), Pharvaris NV's stock price is $16.77. Pharvaris NV's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was $-1.995. Therefore, Pharvaris NV's PE Ratio for today is At Loss.


Pharvaris NV EV-to-FCF Historical Data

The historical data trend for Pharvaris NV's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharvaris NV EV-to-FCF Chart

Pharvaris NV Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial - - -4.76 -2.94 -10.24

Pharvaris NV Quarterly Data
Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.64 -4.94 -7.15 -10.24 -8.46

Competitive Comparison of Pharvaris NV's EV-to-FCF

For the Biotechnology subindustry, Pharvaris NV's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharvaris NV's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharvaris NV's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Pharvaris NV's EV-to-FCF falls into.



Pharvaris NV EV-to-FCF Calculation

Pharvaris NV's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=547.641/-99.742
=-5.49

Pharvaris NV's current Enterprise Value is $547.64 Mil.
Pharvaris NV's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-99.74 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharvaris NV  (NAS:PHVS) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Pharvaris NV's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=16.77/-1.995
=At Loss

Pharvaris NV's share price for today is $16.77.
Pharvaris NV's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.995.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Pharvaris NV EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Pharvaris NV's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharvaris NV (Pharvaris NV) Business Description

Traded in Other Exchanges
Address
Emmy Noetherweg 2, Leiden, NLD, 2333 BK
Pharvaris NV is a clinical-stage company. It is focused on the discovery and development and commercialization of therapies for rare diseases with significant unmet need, initially focused on angioedema and other bradykinin-mediated diseases.